Radiosensitization of human and rodent cell lines by INO-1001,a novel inhibitor of poly(ADP-ribose) polymerase William A. Brock,Luka Milas,etal. Cancer Letters 2004;205:155–160
INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase,enhances tumor response to doxorubicin Kathryn A. Mason,David Valdecanas,et al. Invest New Drugs 2008;26:1–5
Beneficial effects of PJ34 and INO-1001, two novel water-soluble poly(ADP-ribose) polymerase inhibitors, on the consequences of traumatic brain injury in rat Valerie C. Bessona,Zsuzsanna Zsengeller,et al. Brain Research 2005;1041:149– 156
In vitro effect of the potent poly(ADP-ribose) polymerase (PARP) inhibitor INO-1001 alone and in combination with aspirin, eptifibatide, tirofiban,enoxaparin or alteplase on haemostatic parameters Orsolya Tóth , Csaba Szabó,et al Life Sciences 2006;79:317–323
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.